Skip to main content
SpringerLink
Log in

Antithrombotics are prescribed to most outpatients with permanent atrial fibrillation (AF), however the use of vitamin K antagonists decreases with age.

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. FALSTAF Study Group.Influence of age on the prescription of vitamin K antagonists in outpatients with permanent atrial fibrillation in France. Pharmacoepidemiology and Drug Safety 16: 32-38, No. 1, Jan 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antithrombotics are prescribed to most outpatients with permanent atrial fibrillation (AF), however the use of vitamin K antagonists decreases with age.. Pharmacoecon. Outcomes News 525, 7 (2007). https://doi.org/10.2165/00151234-200705250-00019

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705250-00019

Keywords

Search

Navigation